1-207563931-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_000651.6(CR1):c.3654C>T(p.Pro1218=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.01 in 1,479,902 control chromosomes in the GnomAD database, including 1,184 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.014 ( 44 hom., cov: 16)
Exomes 𝑓: 0.0097 ( 1140 hom. )
Consequence
CR1
NM_000651.6 synonymous
NM_000651.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.12
Genes affected
CR1 (HGNC:2334): (complement C3b/C4b receptor 1 (Knops blood group)) This gene is a member of the receptors of complement activation (RCA) family and is located in the 'cluster RCA' region of chromosome 1. The genome is polymorphic at this locus with allele-specific splice variants encoding different isoforms, based on the presence/absence of long homologous repeats (LHRs). The gene encodes a monomeric single-pass type I membrane glycoprotein found on erythrocytes, leukocytes, glomerular podocytes, and splenic follicular dendritic cells. The Knops blood group system is a system of antigens located on this protein. The protein mediates cellular binding to particles and immune complexes that have activated complement. Decreases in expression of this protein and/or mutations in this gene have been associated with gallbladder carcinomas, mesangiocapillary glomerulonephritis, systemic lupus erythematosus, sarcoidosis and Alzheimer's disease. Mutations in this gene have also been associated with a reduction in Plasmodium falciparum rosetting, conferring protection against severe malaria. [provided by RefSeq, May 2020]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 1-207563931-C-T is Benign according to our data. Variant chr1-207563931-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 2639871.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0141 (1593/113012) while in subpopulation NFE AF= 0.0186 (1179/63234). AF 95% confidence interval is 0.0178. There are 44 homozygotes in gnomad4. There are 696 alleles in male gnomad4 subpopulation. Median coverage is 16. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 44 BG gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CR1 | NM_000651.6 | c.3654C>T | p.Pro1218= | synonymous_variant | 22/47 | ENST00000367049.9 | NP_000642.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CR1 | ENST00000367049.9 | c.3654C>T | p.Pro1218= | synonymous_variant | 22/47 | 5 | NM_000651.6 | ENSP00000356016 | P1 | |
ENST00000597497.5 | n.353-10951G>A | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0141 AC: 1593AN: 112978Hom.: 44 Cov.: 16
GnomAD3 genomes
AF:
AC:
1593
AN:
112978
Hom.:
Cov.:
16
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00222 AC: 500AN: 225682Hom.: 13 AF XY: 0.00228 AC XY: 279AN XY: 122604
GnomAD3 exomes
AF:
AC:
500
AN:
225682
Hom.:
AF XY:
AC XY:
279
AN XY:
122604
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00972 AC: 13280AN: 1366890Hom.: 1140 Cov.: 31 AF XY: 0.00989 AC XY: 6738AN XY: 681050
GnomAD4 exome
AF:
AC:
13280
AN:
1366890
Hom.:
Cov.:
31
AF XY:
AC XY:
6738
AN XY:
681050
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0141 AC: 1593AN: 113012Hom.: 44 Cov.: 16 AF XY: 0.0127 AC XY: 696AN XY: 54762
GnomAD4 genome
AF:
AC:
1593
AN:
113012
Hom.:
Cov.:
16
AF XY:
AC XY:
696
AN XY:
54762
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2023 | CR1: BP4, BP7, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at